Zydus Lifesciences Limited — Irbesartan Exporter Profile
Indian Pharmaceutical Exporter · #8 for Irbesartan · $2.4M export value · DGFT Verified
Zydus Lifesciences Limited is the #8 Indian exporter of Irbesartan with $2.4M in export value and 162 verified shipments. Zydus Lifesciences Limited holds a 2.3% market share in Irbesartan exports across 6 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Irbesartan Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Irbesartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $895.8K | 35 | 38.2% |
| SRI LANKA | $609.7K | 36 | 26.0% |
| FRANCE | $414.7K | 57 | 17.7% |
| VIETNAM, DEMOCRATIC REP. OF | $135.1K | 9 | 5.8% |
| SPAIN | $94.7K | 12 | 4.0% |
| VIETNAM DEMOCRATIC REP OF | $78.2K | 4 | 3.3% |
| TANZANIA | $65.4K | 5 | 2.8% |
| VIETNAM | $48.0K | 3 | 2.0% |
| VIETNAM DEMOCRATIC REP. OF | $1.9K | 1 | 0.1% |
Zydus Lifesciences Limited exports Irbesartan to 9 countries. The largest destination is PHILIPPINES accounting for 38.2% of Zydus Lifesciences Limited's Irbesartan shipments, followed by SRI LANKA (26.0%) and FRANCE (17.7%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Irbesartan from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZYDUS HEALTHCARE PHILIPPINES INC. | PHILIPPINES | $670.1K | 22 |
| SUNSHINE HEALTHCARE LANKA LIMITED | SRI LANKA | $487.0K | 32 |
| CENTRE SPECIALITIES PHARMACEUTIQUES | FRANCE | $219.2K | 20 |
| CENTRE SPCIALITS PHARMACEUTIQUES | FRANCE | $179.7K | 36 |
| ZYDUS HEALTHCARE PHILIPPINES INC | PHILIPPINES | $162.1K | 10 |
| DANANG PHARMACEUTICAL MEDICAL | VIETNAM, DEMOCRATIC REP. OF | $127.6K | 5 |
| STATE PHARMACEUTICALS | SRI LANKA | $87.4K | 2 |
| HAPHARCO J.S.C. BRANCH | VIETNAM DEMOCRATIC REP. OF | $68.6K | 7 |
| ABACUS PHARMA (A) LTD | TANZANIA | $65.4K | 5 |
| ZYDUS HEALTHCARE PHILIPPINES INC., | PHILIPPINES | $35.9K | 1 |
Zydus Lifesciences Limited supplies Irbesartan to 22 buyers globally. The largest buyer is ZYDUS HEALTHCARE PHILIPPINES INC. (PHILIPPINES), followed by SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA) and CENTRE SPECIALITIES PHARMACEUTIQUES (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Irbesartan Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $58.2M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. Zydus Lifesciences Limited contributes $2.4M to this total, accounting for 2.3% of India's Irbesartan exports. Zydus Lifesciences Limited ships Irbesartan to 9 countries through 22 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Irbesartan Exports?
Zydus Lifesciences Limited's average Irbesartan shipment value is $15.1K per consignment, based on 162 shipments totaling $2.4M. The largest destination is PHILIPPINES (38.2% of Zydus Lifesciences Limited's Irbesartan exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Irbesartan Exporters?
Zydus Lifesciences Limited ranks #8 among 123 Indian Irbesartan exporters with a 2.3% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($10.8M), MACLEODS PHARMACEUTICALS LTD ($8.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($8.3M). Zydus Lifesciences Limited processed 162 shipments to 6 destination countries.
What Irbesartan Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRBEZYD 300 TAB SALE (10X10) (IRBESARTAN | $110.5K | 4 |
| IRBEZYD 150 TAB (IRBESARTAN) 10 X 10 TNOS | $100.0K | 2 |
| IRBESARTAN TABLETS USP 150MG (IRBESARTAN | $87.4K | 2 |
| IRBEZYD 300 TAB (IRBESARTAN & HYDROCHLOROTHIAZIDE) 10 X 10 TNOS | $84.2K | 2 |
| IRBEZYD 150 TAB SALE (10X10) (IRBESARTAN | $83.4K | 3 |
| IRBESARTAN ZYDUS 150MG TABLETS(IRBESARTAN)OTHER DTLS AS PER INVOICENOS | $76.2K | 12 |
| IRBEZYD 150 TAB (IRBESARTAN) 10 X 10 T | $74.7K | 2 |
| IRBEZYD 150 TAB (IRBESARTAN) 10 X 10 T U | $73.2K | 3 |
| IRBEZYD 300 TAB SALE (10X10)(IRBESARTAN)(10 X 10 T) | $68.5K | 2 |
| IRBEZYD 150 TAB SALE (10X10)(IRBESARTAN) | $55.1K | 3 |
Zydus Lifesciences Limited exports 95 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBEZYD 300 TAB SALE (10X10) (IRBESARTAN with 4 shipments worth $110.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Zydus Lifesciences Limited Compare to Nearest Irbesartan Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MACLEODS PHARMACEUTICALS LIMITED | $3.6M | 89 | 7 | $40.4K |
| 7 | AUROBINDO PHARMA LTD | $2.7M | 251 | 4 | $10.7K |
| 8 | ZYDUS LIFESCIENCES LIMITED ★ | $2.4M | 162 | 6 | $15.1K |
| 9 | INTAS PHARMACEUTICALS LIMITED | $1.8M | 156 | 5 | $11.5K |
| 11 | JUBILANT GENERICS LIMITED | $1.3M | 84 | 7 | $15.1K |
Zydus Lifesciences Limited ranks #8 among 123 Indian Irbesartan exporters. Average shipment value of $15.1K compared to the market average of $473.0K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Irbesartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 284 | 10.6% |
| SAHAR AIR | 197 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 147 | 5.5% |
| DELHI AIR | 135 | 5.1% |
| DELHI AIR CARGO ACC (INDEL4) | 133 | 5.0% |
| JNPT | 129 | 4.8% |
| MUNDRA SEA (INMUN1) | 108 | 4.0% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Irbesartan Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Irbesartan, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 162 individual customs records matching Zydus Lifesciences Limited exporting Irbesartan, covering 95 formulations to 9 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Irbesartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Irbesartan Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current shipment-level data, contact TransData Nexus.